Cibc Private Wealth Group, LLC Forte Biosciences, Inc. Transaction History

Cibc Private Wealth Group, LLC

  • $53.9 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$2.96 - $36.67 $32,560 - $403,370
-11,000 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$31.5 - $42.5 $209,979 - $283,305
-6,666 Reduced 37.73%
11,000 $370,000
Q3 2020

Nov 03, 2020
BUY
$14.71 - $50.69 $259,866 - $895,489
17,666 New
17,666 $857,000
Q3 2020

Oct 29, 2020
SELL
$14.71 - $50.69 $259,881 - $895,540
-17,667 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$13.9 - $24.6 $245,571 - $434,608
17,667 New
17,667 $258,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email